CN101450203A - Oral liquid for treating hemiplegia - Google Patents
Oral liquid for treating hemiplegia Download PDFInfo
- Publication number
- CN101450203A CN101450203A CNA2007101956455A CN200710195645A CN101450203A CN 101450203 A CN101450203 A CN 101450203A CN A2007101956455 A CNA2007101956455 A CN A2007101956455A CN 200710195645 A CN200710195645 A CN 200710195645A CN 101450203 A CN101450203 A CN 101450203A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- oral liquid
- zingiberis recens
- hemiplegia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral liquid for treating hemiplegia which is prepared from components by weight percentage including 1.4-1.9% ginseng, 2.4-2.9% atractylodes, 1.4-1.9% poria, 1.8-2.3% angelica, 1.8-2.3% chuanxiong, 1.4-1.9 white peony root, 1.4-1.9% rehmanniae radix, 1.4-1.9% rehmanniae vaporata, 1.4-1.9% rhizoma arisaematis, 1.4-1.9% rhizoma pinelliae, 1.4-1.9% dried old orange peel, 0.6-1.1% notopterygium root, 0.6-1.1% radix sileris, 1.4-1.9% rhizoma gastrodiae, 1.0-1.5% radix cyathulae, 0.4-0.9% safflower, 0.6-1.1 cassia twig, 1.0-1.5% scutellaria, 0.4-0.9% phellodendron, 1.0-1.5% jujube kernel, 0.4-0.9% combined spicebush, 0.4-0.9% glycyrrhiza, 35.6-36.1% bamboo juice and 35.6-36.1% ginger juice. The oral liquid has characteristics of rapid effect, better culative effect, high curative ratio and patient self-care for treating cerebrovascular disease sequela, facial paralysis, slurred speech and giddy by oral method.
Description
Technical field
The invention belongs to the Chinese drug preparation technique field, relate to a kind of Chinese medicine composition, be specifically related to a kind of oral liquid for the treatment of hemiplegia.
Background technology
Apoplexy is a kind of commonly encountered diseases that generally takes place in the present society, is the difficult problem of motherland's medical circle, especially sequal of cerebrovascular diseases: hemiplegia.Unsatisfactory curative effect.The treatment way that does not have success.
Summary of the invention
The purpose of this invention is to provide a kind of oral liquid for the treatment of hemiplegia, adopt the oral means of traditional medicine decoction, be used for the treatment of sequal of cerebrovascular diseases, hemiplegia, facial hemiparalysis, slurred speech, the vertigo, have basic treatment, the five internal organs are taken into account, the collateral dredging that stimulates the menstrual flow reaches the effect that patient's rehabilitation is taken care of oneself.
The technical solution adopted in the present invention is, a kind of oral liquid for the treatment of hemiplegia, composed of the following components by mass percentage: Radix Ginseng 1.4-1.9%, Rhizoma Atractylodis Macrocephalae 2.4-2.9%, Poria 1.4-1.9%, Radix Angelicae Sinensis 1.8-2.3%, Rhizoma Chuanxiong 1.8-2.3%, Radix Paeoniae Alba 1.4-1.9%, Radix Rehmanniae 1.4-1.9%, Radix Rehmanniae Preparata 1.4-1.9%, Rhizoma Arisaematis 1.4-1.9%, Rhizoma Pinelliae 1.4-1.9%, Pericarpium Citri Reticulatae 1.4-1.9%, Rhizoma Et Radix Notopterygii 0.6-1.1%, Radix Saposhnikoviae 0.6-1.1%, Rhizoma Gastrodiae 1.4-1.9%, Radix Cyathulae 1.0-1.5%, Flos Carthami 0.4-0.9%, Ramulus Cinnamomi 0.6-1.1%, Radix Scutellariae 1.0-1.5%, Cortex Phellodendri 0.4-0.9%, Semen Ziziphi Spinosae 1.0-1.5%, Radix Linderae 0.4-0.9%, Radix Glycyrrhizae 0.4-0.9%, fresh Succus Bambusae 35.6-36.1%, Rhizoma Zingiberis Recens juice 35.6-36.1%, above components contents summation is 100%.
Another technical scheme of the present invention is, the preparation method of above-mentioned Chinese medicine composition is got respectively: the Radix Ginseng of 1.4-1.9% by mass percentage, the Rhizoma Atractylodis Macrocephalae of 2.4-2.9%, the Poria of 1.4-1.9%, the Radix Angelicae Sinensis of 1.8-2.3%, the Rhizoma Chuanxiong of 1.8-2.3%, the Radix Paeoniae Alba of 1.4-1.9%, the Radix Rehmanniae of 1.4-1.9%, the Radix Rehmanniae Preparata of 1.4-1.9%, the Rhizoma Arisaematis of 1.4-1.9%, the Rhizoma Pinelliae of 1.4-1.9%, the Pericarpium Citri Reticulatae of 1.4-1.9%, the Rhizoma Et Radix Notopterygii of 0.6-1.1%, the Radix Saposhnikoviae of 0.6-1.1%, the Rhizoma Gastrodiae of 1.4-1.9%, the Radix Cyathulae of 1.0-1.5%, the Flos Carthami of 0.4-0.9%, the Ramulus Cinnamomi of 0.6-1.1%, the Radix Scutellariae of 1.0-1.5%, the Cortex Phellodendri of 0.4-0.9%, the Semen Ziziphi Spinosae of 1.0-1.5%, the Radix Linderae of 0.4-0.9%, the Radix Glycyrrhizae of 0.4-0.9%, the fresh Succus Bambusae of 35.6-36.1%, the Rhizoma Zingiberis Recens juice of 35.6-36.1%.Said components removed prodrug is added water except fresh Succus Bambusae and the Rhizoma Zingiberis Recens juice, connect and fry in shallow oil twice,, add Rhizoma Zingiberis Recens juice and fresh Succus Bambusae again medicine juice unification place.
Chinese medicine composition of the present invention can the meridian dredging, dispel the wind, eliminate the phlegm, blood stasis dispelling blood, damp eliminating heat, fill blood, strengthening the spleen and stomach, accent the five internal organs, and reach the purpose of curing hemiplegia.
The specific embodiment
Below in conjunction with embodiment the present invention is further described.
A kind of oral liquid for the treatment of hemiplegia of the present invention, composed of the following components by mass percentage: Radix Ginseng 1.4-1.9%, Rhizoma Atractylodis Macrocephalae 2.4-2.9%, Poria 1.4-1.9%, Radix Angelicae Sinensis 1.8-2.3%, Rhizoma Chuanxiong 1.8-2.3%, Radix Paeoniae Alba 1.4-1.9%, Radix Rehmanniae 1.4-1.9%, Radix Rehmanniae Preparata 1.4-1.9%, Rhizoma Arisaematis 1.4-1.9%, Rhizoma Pinelliae 1.4-1.9%, Pericarpium Citri Reticulatae 1.4-1.9%, Rhizoma Et Radix Notopterygii 0.6-1.1%, Radix Saposhnikoviae 0.6-1.1%, Rhizoma Gastrodiae 1.4-1.9%, Radix Cyathulae 1.0-1.5%, Flos Carthami 0.4-0.9%, Ramulus Cinnamomi 0.6-1.1%, Radix Scutellariae 1.0-1.5%, Cortex Phellodendri 0.4-0.9%, Semen Ziziphi Spinosae 1.0-1.5%, Radix Linderae 0.4-0.9%, Radix Glycyrrhizae 0.4-0.9%, fresh Succus Bambusae 35.6-36.1%, Rhizoma Zingiberis Recens juice 35.6-36.1%, above components contents summation is 100%.Said components is removed except fresh Succus Bambusae and the Rhizoma Zingiberis Recens juice.Prodrug is added water connect and to fry in shallow oil twice, after medicine juice unification place, add fresh Succus Bambusae again and Rhizoma Zingiberis Recens juice is made oral liquid, each oral 50 milliliters.
Shang Chen village, bent villages and small towns, Quwo County is burnt beautiful gloomy, suffers from cerebral thrombosis, left hemiplegia, and it is uneven that the trouble foot is put ground, suffers from hands and can touch chin, and finger can not be grabbed thing, a year and a half.Obey this oral liquid, recover normal after 36 days, be as good as with premorbid.
Bent villages and small towns, the Quwo County village, Wenxi County village Jin people's commune suffers from cerebral hemorrhage left side half body and satisfies, and lower limb can be walked reluctantly, suffers from arm and can lift to the tip of the nose place, suffers from hands and can not move 11 months, obeys this oral liquid, and finger can be moving in 10 days, and life in 30 days is taken care of oneself fully.
Claims (2)
1. oral liquid for the treatment of hemiplegia, it is characterized in that, composed of the following components by mass percentage: Radix Ginseng 1.4-1.9%, Rhizoma Atractylodis Macrocephalae 2.4-2.9%, Poria 1.4-1.9%, Radix Angelicae Sinensis 1.8-2.3%, Rhizoma Chuanxiong 1.8-2.3%, Radix Paeoniae Alba 1.4-1.9%, Radix Rehmanniae 1.4-1.9%, Radix Rehmanniae Preparata 1.4-1.9%, Rhizoma Arisaematis 1.4-1.9%, Rhizoma Pinelliae 1.4-1.9%, Pericarpium Citri Reticulatae 1.4-1.9%, Rhizoma Et Radix Notopterygii 0.6-1.1%, Radix Saposhnikoviae 0.6-1.1%, Rhizoma Gastrodiae 1.4-1.9%, Radix Cyathulae 1.0-1.5%, Flos Carthami 0.4-0.9%, Ramulus Cinnamomi 0.6-1.1%, Radix Scutellariae 1.0-1.5%, Cortex Phellodendri 0.4-0.9%, Semen Ziziphi Spinosae 1.0-1.5%, Radix Linderae 0.4-0.9%, Radix Glycyrrhizae 0.4-0.9%, fresh Succus Bambusae 35.6-36.1%, Rhizoma Zingiberis Recens juice 35.6-36.1%, above components contents summation is 100%.
2. oral liquid for the treatment of hemiplegia, it is characterized in that, get the Radix Ginseng of 1.4-1.9% respectively by the quality proportioning, the Rhizoma Atractylodis Macrocephalae of 2.4-2.9%, the Poria of 1.4-1.9%, the Radix Angelicae Sinensis of 1.8-2.3%, the Rhizoma Chuanxiong of 1.8-2.3%, the Radix Paeoniae Alba of 1.4-1.9%, the Radix Rehmanniae of 1.4-1.9%, the Radix Rehmanniae Preparata of 1.4-1.9%, the Rhizoma Arisaematis of 1.4-1.9%, the Rhizoma Pinelliae of 1.4-1.9%, the Pericarpium Citri Reticulatae of 1.4-1.9%, the Rhizoma Et Radix Notopterygii of 0.6-1.1%, the Radix Saposhnikoviae of 0.6-1.1%, the Rhizoma Gastrodiae of 1.4-1.9%, the Radix Cyathulae of 1.0-1.5%, the Flos Carthami of 0.4-0.9%, the Ramulus Cinnamomi of 0.6-1.1%, the Radix Scutellariae of 1.0-1.5%, the Cortex Phellodendri of 0.4-0.9%, the Semen Ziziphi Spinosae of 1.0-1.5%, the Radix Linderae of 0.4-0.9%, the Radix Glycyrrhizae of 0.4-0.9%, the fresh Succus Bambusae of 35.6-36.1%, the Rhizoma Zingiberis Recens juice of 35.6-36.1%, said components is removed except fresh Succus Bambusae and the Rhizoma Zingiberis Recens juice, prodrug is added water, connect and fry in shallow oil twice, with medicine juice unification place, add Rhizoma Zingiberis Recens juice and fresh Succus Bambusae again.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101956455A CN101450203A (en) | 2007-12-05 | 2007-12-05 | Oral liquid for treating hemiplegia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2007101956455A CN101450203A (en) | 2007-12-05 | 2007-12-05 | Oral liquid for treating hemiplegia |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101450203A true CN101450203A (en) | 2009-06-10 |
Family
ID=40732801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007101956455A Pending CN101450203A (en) | 2007-12-05 | 2007-12-05 | Oral liquid for treating hemiplegia |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101450203A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656571A (en) * | 2013-11-26 | 2014-03-26 | 韩必芝 | Sargentgloryvine stem cassia twig electuary and preparation method thereof |
CN104208643A (en) * | 2014-09-25 | 2014-12-17 | 刘建忠 | Chinese medicine for treating hemiplegia and preparation method thereof |
CN104645189A (en) * | 2015-03-05 | 2015-05-27 | 于巧媛 | Traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis |
CN105687791A (en) * | 2016-03-11 | 2016-06-22 | 姜汝明 | Hemiplegia Kangfuling |
-
2007
- 2007-12-05 CN CNA2007101956455A patent/CN101450203A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103656571A (en) * | 2013-11-26 | 2014-03-26 | 韩必芝 | Sargentgloryvine stem cassia twig electuary and preparation method thereof |
CN104208643A (en) * | 2014-09-25 | 2014-12-17 | 刘建忠 | Chinese medicine for treating hemiplegia and preparation method thereof |
CN104645189A (en) * | 2015-03-05 | 2015-05-27 | 于巧媛 | Traditional Chinese medicine composition for treating phlegm stagnation type cerebral arteriosclerosis |
CN105687791A (en) * | 2016-03-11 | 2016-06-22 | 姜汝明 | Hemiplegia Kangfuling |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102430079B (en) | Traditional Chinese medicine composite for treating stranguria | |
CN101028481A (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
CN101134085A (en) | Traditional Chinese medicine for treating apoplectic hemiplegia | |
CN103463586A (en) | Traditional Chinese medicine composition for treating restless legs syndrome | |
CN104043087A (en) | Traditional Chinese medicine composition for treating Raynaud syndrome | |
CN101450203A (en) | Oral liquid for treating hemiplegia | |
CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
CN1181849C (en) | Gastropathy treating Chinese medicine | |
CN101129970A (en) | Traditional Chinese medicine for treating middle and late stage liver cancer | |
CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
CN101612283A (en) | Method for treating cow infertility by using traditional Chinese medicine | |
CN102406765B (en) | Traditional Chinese medicine composition for treating acne | |
CN101129893A (en) | Traditional Chinese medicine for treating cervical spondylosis with diarrhea | |
CN101134099A (en) | Traditional Chinese medicine for treating vertigo caused by vertebrobasilar artery insufficiency | |
CN104147526A (en) | Traditional Chinese medicine particles for treating icteric hepatitis and preparation method thereof | |
CN1686227A (en) | Menstruation regulating powder | |
CN103083632B (en) | Traditional Chinese medicine for treating recurrent aphthae | |
CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
CN105362682A (en) | External-use medicine for treating hypomenorrhea | |
CN103784720A (en) | Traditional Chinese medicinal preparation for reducing blood glucose and urine glucose | |
CN103157006A (en) | Oral traditional Chinese medicine formula for treating osteoarthritis | |
CN1309412C (en) | Medicine composition for treating AIDS and preparing method thereof | |
CN102846892A (en) | Acute icterus type infectious hepatitis treatment decoction | |
CN102058812A (en) | Traditional Chinese medicine for treating swine dyspepsia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090610 |